Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | TNF | P01375 | 2/20 | 0.56 |
| ▸ | KLF5 | Q13887 | 2/20 | 0.56 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.56 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CASP3 | P42574 | 1/20 | 0.43 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.43 |
| ▸ | ESRRG | P62508 | 2/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL446400 | 0.88 | TDP1 (0.69) | TDP1MAPTL3MBTL1TNFKLF5 | |
| SCHEMBL5079219 | 0.84 | MAPT (0.60) | TDP1MAPTL3MBTL1NPSR1RAB9A | |
| SCHEMBL5082794 | 0.84 | MAPT (0.60) | TDP1MAPTL3MBTL1NPSR1RAB9A | |
| SCHEMBL382312 | 0.84 | LMNA (0.56) | TDP1MAPTLMNAALDH1A1TSHR | |
| SCHEMBL8333327 | 0.84 | TDP1 (0.49) | TDP1MAPTL3MBTL1TNFKLF5 | |
| SCHEMBL19875751 | 0.83 | TDP1 (0.63) | TDP1MAPTL3MBTL1TNFKLF5 | |
| SCHEMBL19875749 | 0.83 | TDP1 (0.63) | TDP1MAPTL3MBTL1TNFKLF5 | |
| SCHEMBL14099145 | 0.81 | CES2 (0.55) | TDP1MAPTNPSR1SRD5A2RAB9A | |
| SCHEMBL9878491 | 0.81 | TDP1 (0.69) | TDP1MAPTL3MBTL1TNFKLF5 | |
| SCHEMBL446399 | 0.80 | HDAC1 (0.57) | TDP1MAPTL3MBTL1TNFKLF5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1868984-B1 | BENZOIC ACID ESTER COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO | FERRER INT (ES) | 2017-07-19 | — | — | EP | claimed |
| US-8545816-B2 | 1-(4-methoxyphenyl)-vinyl 4-tert-butylbenzoate; cosmetic, pharmaceutical, personal care and industrial preparations as sunscreens; ultraviolet radiation protection | FERRER INTERNACIONAL, S.A. (ES) | 2013-10-01 | — | — | US | claimed |
| US-20080206158-A1 | Benzoic Acid Ester Compounds, Compositions, Uses and Methods Related Thereto | FERRER INTERNACIONAL, S.A. (ES) | 2008-08-28 | — | — | US | claimed |
| EP-1868984-A2 | BENZOIC ACID ESTER COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO | FERRER INTERNACIONAL, S.A. (ES) | 2007-12-26 | — | — | EP | claimed |
| EP-1707558-A1 | Benzoic acid ester compounds, compositions, uses and methods related thereto | FERRER INTERNACIONAL, S.A. (ES) | 2006-10-04 | — | — | EP | claimed |
| WO-2006100225-A2 | BENZOIC ACID ESTER COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO | FERRER INTERNACIONAL, S. A. (ES) | 2006-09-28 | — | — | WO | claimed |
| US-20260028302-A1 | PROCESS FOR PREPARING BENZOIC ACID ESTERS AND INTERMEDIATES THEREOF | ROKA FURADADA S L (ES) | 2026-01-29 | — | — | US | disclosed |
| US-20250360066-A1 | COMPOSITION COMPRISING A PHOTOCHEMICAL ULTRAVIOLET ABSORBER PRECURSOR AND A COMPOUND FOR INCREASING THEIR PHOTOCHEMICAL CONVERSION RATE | ROKA FURADADA S L (ES) | 2025-11-27 | — | — | US | disclosed |
| EP-4561523-A1 | COMPOSITION COMPRISING A PHOTOCHEMICAL ULTRAVIOLET ABSORBER PRECURSOR AND A COMPOUND FOR INCREASING THEIR PHOTOCHEMICAL CONVERSION RATE | Roka Furadada, SL (ES) | 2025-06-04 | — | — | EP | disclosed |
| CN-119677713-A | Processes for preparing benzoates and intermediates thereof | 罗卡福拉达有限公司 | 2025-03-21 | — | — | CN | disclosed |
| WO-2024013382-A9 | PROCESS FOR PREPARING BENZOIC ACID ESTERS AND INTERMEDIATES THEREOF | ROKA FURADADA, S.L. (ES) | 2024-04-18 | — | — | WO | disclosed |
| WO-2024023286-A1 | COMPOSITION COMPRISING A PHOTOCHEMICAL ULTRAVIOLET ABSORBER PRECURSOR AND A COMPOUND FOR INCREASING THEIR PHOTOCHEMICAL CONVERSION RATE | ROKA FURADADA, S.L. (ES) | 2024-02-01 | — | — | WO | disclosed |
| WO-2024013382-A1 | PROCESS FOR PREPARING BENZOIC ACID ESTERS AND INTERMEDIATES THEREOF | ROKA FURADADA, S.L. (ES) | 2024-01-18 | — | — | WO | disclosed |
| EP-1868984-B1 | BENZOIC ACID ESTER COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO | FERRER INT (ES) | 2017-07-19 | — | — | EP | disclosed |
| US-8545816-B2 | 1-(4-methoxyphenyl)-vinyl 4-tert-butylbenzoate; cosmetic, pharmaceutical, personal care and industrial preparations as sunscreens; ultraviolet radiation protection | FERRER INTERNACIONAL, S.A. (ES) | 2013-10-01 | — | — | US | disclosed |
| US-20080206158-A1 | Benzoic Acid Ester Compounds, Compositions, Uses and Methods Related Thereto | FERRER INTERNACIONAL, S.A. (ES) | 2008-08-28 | — | — | US | disclosed |
| EP-1868984-A2 | BENZOIC ACID ESTER COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO | FERRER INTERNACIONAL, S.A. (ES) | 2007-12-26 | — | — | EP | disclosed |
| EP-1707558-A1 | Benzoic acid ester compounds, compositions, uses and methods related thereto | FERRER INTERNACIONAL, S.A. (ES) | 2006-10-04 | — | — | EP | disclosed |
| WO-2006100225-A2 | BENZOIC ACID ESTER COMPOUNDS, COMPOSITIONS, USES AND METHODS RELATED THERETO | FERRER INTERNACIONAL, S. A. (ES) | 2006-09-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250360066-A1 | COMPOSITION COMPRISING A PHOTOCHEMICAL ULTRAVIOLET ABSORBER PRECURSOR AND A COMPOUND FOR INCREASING THEIR PHOTOCHEMICAL CONVERSION RATE | TYR, PAH, ERCC4 | TDP1 1235/4885MAPT 387/4885L3MBTL1 4885/4885 |
| US-20080206158-A1 | Benzoic Acid Ester Compounds, Compositions, Uses and Methods Related Thereto | VKORC1, CYP51A1, CYP19A1 | TDP1 1082/4885MAPT 2950/4885L3MBTL1 4173/4885 |
| US-20260028302-A1 | PROCESS FOR PREPARING BENZOIC ACID ESTERS AND INTERMEDIATES THEREOF | DHCR24, BCKDK, CYP2B6 | TDP1 1743/4885MAPT 4867/4885L3MBTL1 2464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.